Guvenc KK, Fentoglu O, Calapoglu M, Aksoy F, et al. Periodontal and cardiovascular therapies modify specialized pro-resolving lipid mediator (sPRLM) (LPXA4, PD1, RvE1, RvD1, and MaR1)-mediated pathway: the first pilot clinical study. Clin Oral Investig 2023;27:5549-5558.
PMID: 37535198